Newsroom

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), een toonaangevend bedrijf gespecialiseerd in zeldzame aandoeningen, maakte vandaag bekend dat het primaire eindpunt is voldaan in het Fase 3-gedeelte van de AZURE-1 studie ter beoordeling van brelovitug, een volledig humaan monoklonaal antilichaam in onderzoeksfase dat zich bindt aan HBsAg (hepatitis B-surface-antigeen), voor de behandeling van chronische HDV (chronische hepatitis delta-virus). Deze bekendmaking i...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), azienda leader nel settore delle malattie rare, oggi ha reso noto che l'endpoint primario è stato raggiunto nella parte di Fase 3 dello studio clinico AZURE-1 volto a valutare brelovitug, un anticorpo monoclonale sperimentale completamente umano che si lega all'antigene di superficie dell'epatite B (HBsAg), per il trattamento del virus dell'epatite cronica Delta (HDV). Il testo originale del presente annuncio, red...

MINNEAPOLIS--(BUSINESS WIRE)--U.S. Bank doubles down on its commitment to support small business owners with the launch of its U.S. Bank Business EssentialsTM Visa® Card and U.S. Bank Business EssentialsTM Plus Visa Signature® Card. The cards are designed for small business owners looking for straight-forward rewards on their everyday business purchases. Both offer unlimited 2% cash back on eligible purchases, plus the ability to earn higher cash back when paired with qualifying balances in a q...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NasdaqGS: SMCI). On March 19, 2026, post-market, the U.S. Department of Justice announced the unsealing of an indictment against three individuals associated with the Company, Yih-Shyan Liaw (the Company’s...

LONDON--(BUSINESS WIRE)--  Re: Macquarie Group Limited   USD 30,000,000.00   MATURING: 01-Jul-2030   ISIN: XS3105238953     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Jun-2026 TO 30-Sep-2026 HAS BEEN FIXED AT 4.68 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 30-Sep-2026 WILL AMOUNT TO: USD 11.95 PER USD 1,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: United Utilities Water Finance PLC.   GBP 33,000,000.00   MATURING: 05-Oct-2057   ISIN: XS1694666535     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 05-Apr-2026 TO 05-Oct-2026 HAS BEEN FIXED AT 0.54 PCT   DAY BASIS: ACTUAL/ACTUAL(ISMA)   INTEREST PAYABLE VALUE 05-Oct-2026 WILL AMOUNT TO: GBP 88,409.15 PER GBP 33,000,000.00 DENOMINATION  ...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS). On August 2, 2023, the Company announced its financial results for the quarter ended June 30, 2023, disclosing that it was revising its diluted earnings-per-share ("EPS") guidance range to $6.53 to $6.75 from $6.90 to $7.1...

LONDON--(BUSINESS WIRE)--  Re: Nordic Investment Bank   USD 292,000,000.00   MATURING: 04-Oct-2027   ISIN: US65562YAL20     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 06-Jul-2026 TO 05-Oct-2026 HAS BEEN FIXED AT 3.97 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 05-Oct-2026 WILL AMOUNT TO: USD 3,205,760.82 PER USD 319,781,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: SNB FUNDING LIMITED   AUD 20,000,000.00   MATURING: 27-Jun-2033   ISIN: XS2642669043     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 28-Sep-2026 TO 29-Dec-2026 HAS BEEN FIXED AT 6.53 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 29-Dec-2026 WILL AMOUNT TO: AUD 3,289.82 PER AUD 200,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Bank of Scotland PLC   EUR 34,000,000.00   MATURING: 31-Dec-2029   ISIN: XS0279078496     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 30-Sep-2026 TO 31-Dec-2026 HAS BEEN FIXED AT 2.76 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 31-Dec-2026 WILL AMOUNT TO: EUR 352.54 PER EUR 50,000.00 DENOMINATION  ...